ClinicalTrials.gg
RecruitingNCT05569785Updated Jun 20, 2024

Bariatric Surgery and Exercise Interventions: Effects on Muscle

An interventional study of Resistance Exercise Therapy in Bariatric Surgery Candidate and Obesity, sponsored by University of Nottingham. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-06-20.

Sponsored by University of Nottingham · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Obesity by University of Nottingham — 5 open to participants now, 5 under way, none of them phase 3. Obesity · University of Nottingham.

Planned enrollment
12th of 17
12 · median 24
Started
2023
the only one that year
No phase
15 of 21
4 open now
Registered
17th of 21
by date

Among the 21 studies in Obesity by University of Nottingham, this one is the 12th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2023, is one of 15 with no phase, and was the 17th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

5 of the 21 studies in Obesity by University of Nottingham are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Obesity by University of Nottingham, or all of them as a file.
02

Study summary

The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.

Read the detailed description

A single-centre feasibility research programme based at the Royal Derby Hospital centre of the University of Nottingham. This is an exploratory and feasibility study. Muscle structure and function of 12 patients will be assessed before bariatric surgery and at 6 weeks, and then 10 weeks, after surgery. After 6 weeks, participants will be randomised into two groups. Group 1 will undergo a 4 week Resistance Exercise Training (RET). Group 2 will undergo standard care procedure. The total duration of programme we are aiming for is 13-14 weeks prior to bariatric surgery and exercise intervention for 4 weeks after bariatric surgery.

03

Conditions studied

  • Bariatric Surgery Candidate
  • Obesity

Browse trials for

Keywords

  • resistance exercise therapy
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Obese adults ( greater than or equal to 35 kg/m2)
  • Age range 18-70 years old
  • Scheduled for RYGB surgery or sleeve gastrectomy surgery.
  • Ability to give

Exclusion criteria

Exclusion Criteria:

  • Patients who are not fit or not suitable for RYGB or Sleeve Gastrectomy as per Tier 4 Bariatric Surgery MDT.
  • For those high-risk patients who are fast tracked to surgery, we will exclude patients with a >3 or 4 heart failure status and those with end stage renal failure.
  • greater than or equal to 60
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
12 participants (estimated)

Study arms

  • Active comparator
    Group 1 Resistance Exercise Therapy Feasibility

    One group who have been randomised to receive 4 weeks of Resistance Exercise Therapy to explore the feasibility of introducing such a programme in the bariatric population.

    Other: Resistance Exercise Therapy

  • No intervention
    Group 2 Standard Care

    This group have been randomised to receive standard care post surgery.

Interventions

  • OtherResistance Exercise Therapy

    4 weeks of Resistance Exercise Therapy. This is a 4 week resistance exercise training programme that can be completed at home. The programme is designed to be progressive. It was designed by a bariatric physiotherapist and an exercise physiologist. This exercise programme will be discussed at the screening visit, educational material will be provided to the participants who are randomised to the intervention RET group. Safety advice will be given to each eligible participant to ensure that if they feel unwell, develop chest pain/tightness, then they must seek advice from GP/urgent care if necessary. The exercises will need to be performed at least three times a week. Compliance will be monitored with Fitbit downloads at each visit. Fitbits will be worn during exercise sessions only.

06

What researchers measure

Primary outcomes

  1. To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness.

    This will be assessed using muscle ultrasound and units (mm)

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks

  2. To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2)

    This will be assessed using muscle ultrasound

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks

  3. Assessment of percentage of patients who were retained throughout the intervention arm of the study

    To be measured as percentage.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks

  4. Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use.

    This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks

  5. Assessment of number of patients who were recruited to the study

    This assessment will be measured as a simple numeric value

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks

Secondary outcomes

  1. Fasting glucose

    These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be mmol .

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface.

  2. Skeletal muscle architecture (fibre length)

    An ultrasound scan will be used for the purpose of this measurement. Units (mm).

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day

  3. Muscle fatigability (maximum voluntary contractions)

    This is the maximal force-generating capacity of a muscle or group of muscles

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days.

  4. Lean body mass using BIA and D3 creatine

    These are stable biomarkers that have been previously used in research. It acts in the body as creatine, which is a naturally occurring substance.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later..

  5. Motor control in force tracking

    As part of the Short Physical Performance Battery Test

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  6. Balance using the Timed Up and Go (TUG) test

    As part of the Short Physical Performance Battery Test

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  7. Balance in Gait and Motion testing

    As part of the Short Physical Performance Battery Test

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  8. Hand grip strength

    The purpose of the handgrip strength test is to measure the maximum isometric strength of the hand and forearm muscles

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  9. Predicted maximum oxygen consumption (VO2 max) in step box test

    As part of the Short Physical Performance Battery Test

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  10. Skin fold and body circumference measurements

    To assess for any interval change

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  11. Quality of life measurements using IPAQ questionnaire

    Questionnaires are performed to standardise the assessment of quality of life from the patient perspective. IPAQ questionnaire contains open-ended questions surrounding individuals' last 7-day recall of physical activity

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  12. insulin resistance (HOMA-IR)

    These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be nmol/L.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  13. Skeletal muscle architecture (pennation angle)

    An ultrasound scan will be used for the purpose of this measurement, units will be in degrees.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

  14. Quality of life measurements using SF-36 questionnaire

    Questionnaires are performed to standardise the assessment of quality of life from the patient perspective.This questionnaire uses a likert scale as means of assessment.

    Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.

07

Study locations

1 of 1 sites recruiting
  • COMAP
    Derby, United Kingdom
    Recruiting
    • Rebekah Wilmington, BMBSBMedSci · Contact
08

References and documents

Publications

  • Wadstrom C, Backman L, Forsberg AM, Nilsson E, Hultman E, Reizenstein P, Ekman M. Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty. Obes Surg. 2000 Jun;10(3):203-13. doi: 10.1381/096089200321643313. PubMed 10932257 ↗
  • Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T, Patel S, King NJ, Carter JT, Rogers SJ, Posselt AM, Stewart L, Shoback DM, Schafer AL. Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery. J Clin Endocrinol Metab. 2019 Mar 1;104(3):711-720. doi: 10.1210/jc.2018-00952. PubMed 30657952 ↗
  • Haeffener MP, Ferreira GM, Barreto SS, Arena R, Dall'Ago P. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J. 2008 Nov;156(5):900.e1-900.e8. doi: 10.1016/j.ahj.2008.08.006. Epub 2008 Oct 5. PubMed 19061704 ↗
  • Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim DJ, Vassiliou MC, Feldman LS. Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc. 2013 Apr;27(4):1072-82. doi: 10.1007/s00464-012-2560-5. Epub 2012 Oct 9. PubMed 23052535 ↗
  • Santa Mina D, Clarke H, Ritvo P, Leung YW, Matthew AG, Katz J, Trachtenberg J, Alibhai SM. Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis. Physiotherapy. 2014 Sep;100(3):196-207. doi: 10.1016/j.physio.2013.08.008. Epub 2013 Nov 13. PubMed 24439570 ↗
  • Herring LY, Stevinson C, Carter P, Biddle SJH, Bowrey D, Sutton C, Davies MJ. The effects of supervised exercise training 12-24 months after bariatric surgery on physical function and body composition: a randomised controlled trial. Int J Obes (Lond). 2017 Jun;41(6):909-916. doi: 10.1038/ijo.2017.60. Epub 2017 Mar 6. PubMed 28262676 ↗

Individual participant data

Plan to share: No — No plan to do so

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Jun 2024, 15 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 15 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2022
First posted
Oct 6, 2022
StartActual
Mar 1, 2023
Primary completionEst.
Jun 30, 2024
CompletionEst.
Dec 1, 2024
Last update
Jun 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05569785
Responsible party
Sponsor
First posted
Oct 6, 2022
Start date
Mar 1, 2023
Primary completion
Jun 30, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Jun 20, 2024

Study contacts

Iskandar Idris
Contact
iskandar.idris@nottingham.ac.uk
01332724605
Rebekah Wilmington
Contact
rebekah.wilmington@nottingham.ac.uk
01332724605

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion